Thumbnail Image
Publication

Review of 340B Drug Pricing Program

House Committee on Energy and Commerce
Citations
Altmetric:
Abstract
The House Committee on Energy and Commerce issued a Majority Staff Report on the 340B Drug Pricing Program. The report contains recommendations.
Date
2018-01-10
Document Type
House Majority Staff Report
Serial Number
Document Length
80 pages
Congress
115
Show all metadata
Files
Thumbnail Image
2018-01-10_R-Review_340B-115C.pdf
Adobe PDF, 1.31 MB
URI
https://hdl.handle.net/20.500.14300/2735
Relation
DOI
Keywords
Staff Reports, House, Republican
PAP Major Code
3: Health
PAP Minor Code
335: Prescription Drug Coverage and Costs
Cited Hearings
• House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations, hearing on “Examining How Covered Entities Utilize the 340B Drug Pricing Program,” 115th Cong., H.Hrg. 115-63, (2017, October 11)
• Senate Committee on Labor and Human Resources, hearing on “Public Health Clinic Prudent Pharmaceutical Purchasing Act,” 102nd Cong. (1991, October 16)
• House Committee on Energy and Commerce, Subcommittee on Health, hearing on “Examining The 340B Drug Pricing Program,” 114th Cong., H.Hrg. 114-25, (2015, March 24)
• House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations, hearing on “Examining HRSA's Oversight Of The 340B Drug Pricing Program,” 115th Cong., H.Hrg. 115-46, (2017, July 18)
Press Releases and Contextual Information
Collections
House Committee on Energy and Commerce